Celon Pharma S.A. (WSE:CLN) is looking actively for a partner the drug Salmex in the USA, Vice-President Jacek Glinka revealed on March 03, 2021. He believes the search for a new partner to develop Salmex in the USA may take up to a dozen or so months. However, Celon Pharma is not averse to the thought of running the Salmex project by itself. Celon Pharma announced on March 2, 2021 that it had ended cooperation with Lupin Atlantis Holdings regarding the commercialisation of Salmex in 5 countries, including the USA.